Literature DB >> 23259877

Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.

S S Saleh1, M Q Al-Ramahi, F A Al Kazaleh.   

Abstract

This is a retrospective study comparing the efficacy and safety of atosiban and nifedipine in the suppression of pre-term labour. A total of 75 patients were included in this study; 34 received atosiban and 41 received nifedipine. There were no statistically significant differences in the baseline characteristics for both groups. A total of 68.3% of women in the atosiban group remained undelivered at 7 days or more, compared with 64.7% in the nifedipine group, which was not statistically significant. Average birth weight, admission to the neonatal intensive care unit and mode of delivery were similar in both groups. However, the gestational age at delivery was significantly higher in the nifedipine group. We concluded that atosiban and nifedipine are effective in delaying delivery for 7 days or more in women presenting with pre-term labour. They have the same efficacy and associated minor side-effects. However, flushing, palpitation and hypotension were significantly higher in the nifedipine group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23259877     DOI: 10.3109/01443615.2012.721822

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  4 in total

1.  A Prospective Case-control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in In vitro Fertilization-embryo Transfer Program.

Authors:  Vineet Mishra; Himani Agarwal; Sugandha Goel; Priyankur Roy; Sumesh Choudhary; Sunita Lamba
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun

2.  In silico analysis of the Mus musculus uterine gene expression landscape during pregnancy identifies putative upstream regulators for labour.

Authors:  Febilla Fernando; Souad Boussata; Aldo Jongejan; Joris A van der Post; Gijs Afink; Carrie Ris-Stalpers
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

3.  A double-blinded, randomized, placebo-controlled trial assessing the effects of nifedipine on embryo transfer: Study protocol.

Authors:  Kelvin Kl Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Does nifedipine improve outcomes of embryo transfer?: Interim analysis of a randomized, double blinded, placebo-controlled trial.

Authors:  Kelvin Kwok Lap Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.